Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHRQ’s Clancy, OMB’s Emanuel Key Figures On Comparative Research Cmte.

Executive Summary

The Federal Coordinating Committee on Comparative Effectiveness Research includes Agency for Health Care Research & Quality Administrator Carolyn Clancy and Office of Management & Budget Special Advisor Ezekiel Emanuel

You may also be interested in...



NICE Lessons On What To Expect from U.S. Comparative Effectiveness

Costs appear to be an almost inevitable part of the expanded federal comparativeness research program, and the UK's 10-year old cost-effectiveness watchdog, the National Institute of Clinical Excellence, offers strategic clues for how the U.S. biopharma industry should respond, experts from the law firm Sidley Austin law firm advise

NICE Lessons On What To Expect from U.S. Comparative Effectiveness

Costs appear to be an almost inevitable part of the expanded federal comparativeness research program, and the UK's 10-year old cost-effectiveness watchdog, the National Institute of Clinical Excellence, offers strategic clues for how the U.S. biopharma industry should respond, experts from the law firm Sidley Austin law firm advise

Stakeholders Want More Say In Federal Comparative Effectiveness Effort

Private stakeholders representing a variety of interests brought a common message to the Federal Coordinating Council for Comparative Effectiveness Research's first public meeting: we want more involvement

Related Content

Topics

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel